Pharmaceutical Technology Europe-07-01-2009

Pharmaceutical Technology Europe

Expression systems royalties battle

July 01, 2009

Biopharmaceuticals

21

7

Biopharmaceutical companies generally try to avoid paying royalties on novel technologies, including novel expression systems, in part because of the inability to predict revenue flow after a product is commercialized.

Dynamic avalanching accurately assesses flowability and quality

July 01, 2009

Analytical

21

7

Cefaclor is a β-lactam cephalosporin antibiotic that has a wide particle size distribution. Because of the nonporous nature of the material, the specific surface area value accounts for a significant amount of fine particles possibly present in the samples under analysis.

Penny-wise, pound-foolish

July 01, 2009

Outsourcing review

21

7

During the past decade, big pharmaceutical companies have been making major efforts to restructure their manufacturing networks. In their haste to shed costs and assets, however, some may be adding risk to their product supply chains.

Pharma's Facebook

July 01, 2009

Information technology

21

7

Social media is big news. From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minutetominute within huge databases of content that they themselves create.